Delhi: Doctors Request Preference Of Covishield Over Covaxin

In a letter addressed to the medical superintendent, the resident doctors of Delhi's Ram Manohar Lohia Hospital have expressed their apprehension towards Bharat Biotech's Covaxin due to inadequate trial. The doctors instead entreated to use the Serum Institute of India's Covishield vaccine. The decision drew criticism as the panel approved just a day after asking Bharat Biotech to provide more evidence. Reportedly, Covaxin is in its Phase-III trials.